162 related articles for article (PubMed ID: 38783953)
21. Population pharmacokinetic study of cyclosporine in Chinese renal transplant recipients.
Chen B; Zhang W; Gu Z; Li J; Zhang Y; Cai W
Eur J Clin Pharmacol; 2011 Jun; 67(6):601-12. PubMed ID: 21161198
[TBL] [Abstract][Full Text] [Related]
22. Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes.
Hu C; Yin WJ; Li DY; Ding JJ; Zhou LY; Wang JL; Ma RR; Liu K; Zhou G; Zuo XC
Eur J Clin Pharmacol; 2018 Nov; 74(11):1437-1447. PubMed ID: 30019212
[TBL] [Abstract][Full Text] [Related]
23. Effects of CYP3A5 genotypes, ABCB1 C3435T and G2677T/A polymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patients.
Zhu L; Yang J; Zhang Y; Jing Y; Zhang Y; Li G
Xenobiotica; 2015; 45(9):840-6. PubMed ID: 25869250
[TBL] [Abstract][Full Text] [Related]
24. External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients.
Zhao CY; Jiao Z; Mao JJ; Qiu XY
Br J Clin Pharmacol; 2016 May; 81(5):891-907. PubMed ID: 26574188
[TBL] [Abstract][Full Text] [Related]
25. Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients.
Benkali K; Prémaud A; Picard N; Rérolle JP; Toupance O; Hoizey G; Turcant A; Villemain F; Le Meur Y; Marquet P; Rousseau A
Clin Pharmacokinet; 2009; 48(12):805-16. PubMed ID: 19902988
[TBL] [Abstract][Full Text] [Related]
26. Impact of the CYP3A5 genotype on the distributions of dose-adjusted trough concentrations and incidence of rejection in Japanese renal transplant recipients receiving different tacrolimus formulations.
Niioka T; Kagaya H; Saito M; Inoue T; Numakura K; Yamamoto R; Habuchi T; Satoh S; Miura M
Clin Exp Nephrol; 2017 Oct; 21(5):787-796. PubMed ID: 28271256
[TBL] [Abstract][Full Text] [Related]
27. Pharmacogenomic Analysis of CYP3A5*3 and Tacrolimus Trough Concentrations in Vietnamese Renal Transplant Outcomes.
Nguyen TVA; Le BH; Nguyen MT; Le VT; Tran VT; Le DT; Vu DAM; Truong QK; Le TH; Nguyen HTL
Pharmgenomics Pers Med; 2024; 17():53-64. PubMed ID: 38332855
[TBL] [Abstract][Full Text] [Related]
28. Effects of CPY3A5 Genetic Polymorphisms on the Pharmacokinetics of Extendedrelease and Immediate-release Tacrolimus Formulations in Renal Transplant Recipients: A Systematic Review and Meta-analysis.
Xie Q; Xiang Q; Liu Z; Mu G; Zhou S; Zhang Z; Ma L; Cui Y
Curr Drug Metab; 2021; 22(10):758-771. PubMed ID: 34525930
[TBL] [Abstract][Full Text] [Related]
29. Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese pediatric hematopoietic stem cell transplantation patients.
Wang D; Chen X; Xu H; Li Z
Xenobiotica; 2020 Feb; 50(2):178-185. PubMed ID: 30938547
[TBL] [Abstract][Full Text] [Related]
30. A joint population pharmacokinetic model to assess the high variability of whole-blood and intracellular tacrolimus in early adult renal transplant recipients.
Mao J; Zeng F; Qin W; Hu M; Xu L; Cheng F; Zhong M; Zhang Y
Int Immunopharmacol; 2024 Jun; 137():112535. PubMed ID: 38908078
[TBL] [Abstract][Full Text] [Related]
31. Tacrolimus Population Pharmacokinetics and Multiple CYP3A5 Genotypes in Black and White Renal Transplant Recipients.
Campagne O; Mager DE; Brazeau D; Venuto RC; Tornatore KM
J Clin Pharmacol; 2018 Sep; 58(9):1184-1195. PubMed ID: 29775201
[TBL] [Abstract][Full Text] [Related]
32. Comparison of tacrolimus and cyclosporin A in CYP3A5 expressing Chinese de novo kidney transplant recipients: a 2-year prospective study.
Liu LS; Li J; Chen XT; Zhang HX; Fu Q; Wang HY; Xiong YY; Liu S; Liu XM; Li JL; Huang M; Wang CX
Int J Clin Pract Suppl; 2015 May; (183):43-52. PubMed ID: 26177348
[TBL] [Abstract][Full Text] [Related]
33. Dose tailoring of tacrolimus based on a non-linear pharmacokinetic model in children with refractory nephrotic syndrome.
Li L; Zhu M; Li DY; Guo HL; Hu YH; Xu ZY; Jing X; Chen F; Zhao F; Li YM; Xu J; Jiao Z
Int Immunopharmacol; 2021 Sep; 98():107827. PubMed ID: 34284341
[TBL] [Abstract][Full Text] [Related]
34. Effect of CYP3A5 and ABCB1 Gene Polymorphisms on Tacrolimus Blood Concentration in Renal Transplant Recipients.
Yildirim E; Şahin G; Kaltuş Z; Çolak E
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710427
[TBL] [Abstract][Full Text] [Related]
35. Limited Sampling Strategy for the Estimation of Tacrolimus Area Under the Concentration-Time Curve in Chinese Adult Liver Transplant Patients.
Liu XX; Xu BM; Chen H; Song YY; Yang WH; Chen B
Pharmacology; 2016; 98(5-6):229-241. PubMed ID: 27449772
[TBL] [Abstract][Full Text] [Related]
36. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E
Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
[TBL] [Abstract][Full Text] [Related]
37. Population pharmacokinetic study of tacrolimus in pediatric patients with primary nephrotic syndrome: A comparison of linear and nonlinear Michaelis-Menten pharmacokinetic model.
Huang L; Liu Y; Jiao Z; Wang J; Fang L; Mao J
Eur J Pharm Sci; 2020 Feb; 143():105199. PubMed ID: 31862313
[TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetics of tacrolimus in children with nephrotic syndrome.
Hao GX; Huang X; Zhang DF; Zheng Y; Shi HY; Li Y; Jacqz-Aigrain E; Zhao W
Br J Clin Pharmacol; 2018 Aug; 84(8):1748-1756. PubMed ID: 29637588
[TBL] [Abstract][Full Text] [Related]
39. Tacrolimus Exposure Prediction Using Machine Learning.
Woillard JB; Labriffe M; Debord J; Marquet P
Clin Pharmacol Ther; 2021 Aug; 110(2):361-369. PubMed ID: 33253425
[TBL] [Abstract][Full Text] [Related]
40. A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach.
Andreu F; Colom H; Elens L; van Gelder T; van Schaik RHN; Hesselink DA; Bestard O; Torras J; Cruzado JM; Grinyó JM; Lloberas N
Clin Pharmacokinet; 2017 Aug; 56(8):963-975. PubMed ID: 28050888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
